497-37-0 V367XM6FYD exo-Norborneol exo-Bicyclo(2.2.1)heptan-2-ol Bicyclo(2.2.1)heptan-2-ol, (1R,2R,4S)-rel- 2-Norbornanol, exo- (8CI) AI3-51349 EINECS 207-845-6 exo-Norbornanol exo-2-Norbornanol exo-2-Norborneol exo-Norbornyl alcohol exo-2-Norbornyl alcohol NSC 167460 UNII-V367XM6FYD CAS 497-37-0
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 497-37-0 |
| Molecular Formula | C7H12O |
| Molecular Weight | 112.17 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
497-37-0 V367XM6FYD exo-Norborneol exo-Bicyclo(2.2.1)heptan-2-ol Bicyclo(2.2.1)heptan-2-ol, (1R,2R,4S)-rel- 2-Norbornanol, exo- (8CI) AI3-51349 EINECS 207-845-6 exo-Norbornanol exo-2-Norbornanol exo-2-Norborneol exo-Norbornyl alcohol exo-2-Norbornyl alcohol NSC 167460 UNII-V367XM6FYD (CAS 497-37-0) reference standard, produced by CATO (ISO 17034 / CNAS / ANAB accredited). Molecular formula: C7H12O. Molecular weight: 112.17 g/mol. Trusted by 10,000+ laboratories worldwide for pharmaceutical analysis and QC.
Physical & Chemical Properties
| Molecular Formula | C7H12O |
| Molecular Weight | 112.17 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | Stable under recommended storage conditions |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 1957 |
Recommended Standards
- 1-Butanethiol sodium salt 4779-86-6 Sodium 1-butanethiolate (CAS 4779-86-6)
- 5166-53-0 3-Hexen-2-one, 5-methyl- 5-Methylhex-3-en-2-one 3-01-00-03005 (Beilstein Handbook Reference) AI3-22171 BRN 1720101 EINECS 225-950-5 FEMA No. 3409 5-Methyl-3-hexen-2-one 2-Oxo-5-methylhex-3-ene (CAS 5166-53-0)
- 2,2-Dimethylcyclopentanone 4541-32-6 ZLE0003 zlchem 1228 (CAS 4541-32-6)
- 4-Amino-5,5-dimethylfuran-2(5H)-one (CAS 99563-92-5)
- 5-(M-tolyl)-1,2,4-oxadiazol-3-amine (CAS 1017521-44-6)
- 4-HPR 65646-68-6 D08JAC Fenretinide Fenretinide (Ewing's sarcoma), Cancer Research UK Fenretinide (ILE formulation), Children's Hospital LA Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx Fenretinide (intravenous, cancer), SciTech Development Fenretinide (iv), Children's Hospital LA Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products Fenretinide (oral, AMD), Sytera Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University Fenretinide (soft gel capsule, AMD), ReVision Therapeutics Fenretinide (soft gel capsule, AMD), Sirion Fenretinide (topical, actinic keratosis and cancer), SciTech Development LXS/4-HPR N-(4-hydroxyphenyl)retinamide RT-101 ST-602 SYT-101 (CAS 65646-68-6)
- 1-(1-Ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-2,2,2-trifluoroethanone (CAS 1245822-67-6)
- 1-(2-Chloroethoxy)-2-isopropoxybenzene (CAS 915921-87-8)
- 5-((Tert-butoxycarbonyl)amino)bicyclo[3.1.1]Heptane-1-carboxylic acid (CAS 1035325-28-0)
- Sperm Peptide P10G (H-2424.0001) (CAS 137353-73-2)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com